Wird geladen...
Crizanlizumab for the Prevention of Vaso-Occlusive Pain Crises in Sickle Cell Disease
Objective: To review the efficacy and safety of crizanlizumab (Adakveo) in the prevention of vaso-occlusive pain crises in sickle cell disease. Data Sources: An English-language literature search of PubMed, MEDLINE, and Ovid (1946 to January 2021) was completed using the terms crizanlizumab, SEG101,...
Gespeichert in:
| Veröffentlicht in: | J Pharm Technol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8255978/ https://ncbi.nlm.nih.gov/pubmed/34752581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/87551225211008460 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|